Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway

• Gangjun Yuan,
• Xin Chen,
• Zhuowei Liu,
• Wensu Wei,
• Qinghai Shu,
• Hussein Abou-Hamdan,
• Lijuan Jiang,
• Xiangdong Li,
• Rixin Chen,
• Laurent Désaubry,
• Fangjian Zhou,
• Dan Xie

Affiliations

Gangjun Yuan

State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center

Xin Chen

State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center

Zhuowei Liu

Department of Urology, Sun Yat-sen University Cancer Center

Wensu Wei

State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center

Qinghai Shu

School of Material Science and Engineering, Beijing Institute of Technology

Hussein Abou-Hamdan

Therapeutic Innovation Laboratory, UMR7200, CNRS/University of Strasbourg

Lijuan Jiang

State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center

Xiangdong Li

State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center

Rixin Chen

Department of Urology, Sun Yat-sen University Cancer Center

Laurent Désaubry

Therapeutic Innovation Laboratory, UMR7200, CNRS/University of Strasbourg

Fangjian Zhou

State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center

Dan Xie

State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center